[artículo] 
inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 1 (Enero) . - pp. 32-40

Título :	A double blind, placebo controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression
Tipo de documento:	texto impreso
Autores:	Andrew D. Krystal, Autor ; John R. Harsh, Autor ; Ronghua Yang, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 32-40
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Compuestos de bencidrilo, Estimulantes del sistema nervioso central, Presión positiva, Trastorno depresivo mayor, Trastornos de somnolencia excesiva, Trastorno distímico, Síndromes de apnea del sueño.
Resumen:	Treatment of excessive sleepiness in the context of obstructive sleep apnea (OSA) may be particularly difficult in those with depression because depression and/or antidepressant medications may cause sleepiness and fatigue in addition to that due to the OSA. This study evaluating armodafinil, a nonamphetamine wakefulness-promoting medication, is the first trial for treatment of excessive sleepiness in patients with treated OSA and comorbid depression.
Link:	./index.php?lvl=notice_display&id=28123

[artículo] A double blind, placebo controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression [texto impreso] / Andrew D. Krystal, Autor ; John R. Harsh, Autor ; Ronghua Yang, Autor . - 2022 . - pp. 32-40.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 1 (Enero) . - pp. 32-40

Palabras clave:	Antidepresivos, Compuestos de bencidrilo, Estimulantes del sistema nervioso central, Presión positiva, Trastorno depresivo mayor, Trastornos de somnolencia excesiva, Trastorno distímico, Síndromes de apnea del sueño.
Resumen:	Treatment of excessive sleepiness in the context of obstructive sleep apnea (OSA) may be particularly difficult in those with depression because depression and/or antidepressant medications may cause sleepiness and fatigue in addition to that due to the OSA. This study evaluating armodafinil, a nonamphetamine wakefulness-promoting medication, is the first trial for treatment of excessive sleepiness in patients with treated OSA and comorbid depression.
Link:	./index.php?lvl=notice_display&id=28123